美国国立卫生研究院资助血管外科医生的情况罕见
该研究于2022年4月检索NIH RePORTER数据库,纳入以血管外科医生为项目负责人的在研项目,评估NIH对血管外科医生的资助范围及是否覆盖SVS研究优先方向。结果显示仅1%(41/4037)的美国血管外科医生获得NIH资助,共55项在研奖项,75%为基础或转化研究,腹主动脉瘤与周围动脉疾病合计占54%,三个SVS研究优先方向无任何项目涉及。
要点
- 美国仅1%(41/4037)的血管外科医生获得NIH资助,共55项在研奖项。
- 58%(n=32)的奖项为R01资助,75%(n=41)为基础或转化研究项目。
- 腹主动脉瘤与周围动脉疾病合计占54%(n=30),三个SVS研究优先方向无项目涉及。
核心结论
- NIH对血管外科医生的资助罕见,且以聚焦腹主动脉瘤和周围动脉疾病的基础或转化科学项目为主。
- 女性在获资助的血管外科医生中占比良好。
- 多数SVS研究优先方向获得NIH资助,但仍有三个SVS研究优先方向尚无NIH资助项目涉及。
- 未来应致力于增加获得NIH资助的血管外科医生数量,并确保所有SVS研究优先方向获得NIH资助。
研究设计与样本
- 2022年4月检索NIH RePORTER数据库中的在研项目,仅纳入血管外科医生担任项目负责人的项目。
- 从NIH RePORTER数据库提取资助特征,通过检索机构简介获取项目负责人人口学与学术背景信息。
- 共纳入55项在研NIH奖项,对应41名血管外科医生。
主要发现
- 美国所有血管外科医生中仅1%(41/4037)获得NIH资助。
- 获资助血管外科医生平均完成培训后16.3年;37%(n=15)为女性。
- 多数奖项(58%;n=32)为R01资助。
- 在研NIH资助项目中,75%(n=41)为基础或转化研究项目,25%(n=14)为临床或卫生服务研究项目。
- 腹主动脉瘤和周围动脉疾病是最常获资助的疾病领域,合计占54%(n=30)的项目。
关键数值与推荐
- 三个SVS研究优先方向未获任何当前NIH资助项目涉及。
- 多数SVS研究优先方向获得NIH资助。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The National Institutes of Health (NIH) is an essential source of funding for vascular surgeons conducting research. NIH funding is frequently used to benchmark institutional and individual research productivity, help determine eligibility for academic promotion, and as a measure of scientific quality. We sought to appraise the current scope of NIH funding to vascular surgeons by appraising the characteristics of NIH-funded investigators and projects. In addition, we also sought to determine whether funded grants addressed recent Society for Vascular Surgery (SVS) research priorities. METHODS: In April 2022, we queried the NIH Research Portfolio Online Reporting Tools Expenditures and Results (RePORTER) database for active projects. We only included projects that had a vascular surgeon as a principal investigator. Grant characteristics were extracted from the NIH Research Portfolio Online Reporting Tools Expenditures and Results database. Principal investigator demographics and academic background information were identified by searching institution profiles. RESULTS: There were 55 active NIH awards given to 41 vascular surgeons. Only 1% (41/4037) of all vascular surgeons in the United States receive NIH funding. Funded vascular surgeons are an average of 16.3 years out of training; 37% (n = 15) are women. The majority of awards (58%; n = 32) were R01 grants. Among the active NIH-funded projects, 75% (n = 41) are basic or translational research projects, and 25% (n = 14) are clinical or health services research projects. Abdominal aortic aneurysm and peripheral arterial disease are the most commonly funded disease areas and together accounted for 54% (n = 30) of projects. Three SVS research priorities are not addressed by any of the current NIH-funded projects. CONCLUSIONS: NIH funding of vascular surgeons is rare and predominantly consists of basic or translational science projects focused on abdominal aortic aneurysm and peripheral arterial disease research. Women are well-represented among funded vascular surgeons. Although the majority of SVS research priorities receive NIH funding, three SVS research priorities are yet to be addressed by NIH-funded projects. Future efforts should focus on increasing the number of vascular surgeons receiving NIH grants and ensuring all SVS research priorities receive NIH funding.
引用
- Mirzaie AA, Cooper MA, Weaver ML, et al. National Institutes of Health funding among vascular surgeons is rare. J Vasc Surg. 2023. PMID: 37327950. doi:10.1016/j.jvs.2023.05.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。